Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma

Journal of Clinical Oncology

Volumn 24, Issue 2, 2006, Pages 228-240

  Jüttner, Stefan ^a   Wißmann, Christoph ^a   Jöns, Thomas ^a   Vieth, Michael ^a   Hertel, Johannes ^a   Gretschel, Stephan ^a   Schlag, Peter M ^a   Kemmner, Wolfgang ^a   Höcker, Michael ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; LYMPHATIC ENDOTHELIAL CELL MARKER 1 ANTIBODY; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL DENSITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH MUCOSA; ADENOCARCINOMA; CHEMISTRY; DISEASE FREE SURVIVAL; GENETICS; MIDDLE AGED; MORTALITY; STOMACH TUMOR; TUMOR CELL LINE; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 33644825389     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.00.3467     Document Type: Article

References (59)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2:533-543, 2001
2. Hohenberger P, Gretschel S: Gastric cancer. Lancet 362:305-315, 2003
3. Maehara Y, Kakeji Y, Koga T, et al: Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery 131:S85-S91, 2002
4. Tunaci M: Carcinoma of stomach and duodenum: Radiologic diagnosis and staging. Eur J Radiol 42:181-192, 2002
5. Yancopoulos GD, Davis S, Gale NW, et al: Vascular-specific growth factors and blood vessel formation. Nature 407:242-248, 2000
6. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 407:249-257, 2000
7. Stacker SA, Achen MG, Jussila L, et al: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573-583, 2002
8. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 9:669-676, 2003
9. Karkkainen MJ, Petrova TV: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19:5598-5605, 2000
10. Veikkola T, Karkkainen M, Claesson-Welsh L, et al: Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60:203-212, 2000
11. Stacker SA, Stenvers K, Caesar C, et al: Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274:32127-32136, 1999
12. Joukov V, Sorsa T, Kumar V, et al: Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911, 1997
13. McColl BK, Baldwin ME, Roufail S, et al: Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med 198:863-868, 2003
14. Paavonen K, Puolakkainen P, Jussila L, et al: Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156:1499-1504, 2000
15. White JD, Hewett PW, Kosuge D, et al: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 62:1669-1675, 2002
16. Onogawa S, Kitadai Y, Tanaka S, et al: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95:32-39, 2004
17. Yokoyama Y, Charnock-Jones DS, Licence D, et al: Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 9:1361-1369, 2003
18. Yokoyama Y, Charnock-Jones DS, Licence D, et al: Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88:237-244, 2003
19. Nakamura Y, Yasuoka H, Tsujimoto M, et al: Prognostic significance of vascular endothelial growth factor d in breast carcinoma with long-term follow-up. Clin Cancer Res 9:716-721, 2003
20. Arinaga M, Noguchi T, Takeno S, et al: Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 97:457-464, 2003
21. Nakamura Y, Yasuoka H, Tsujimoto M, et al: Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Clin Cancer Res 9:5313-5317, 2003
22. Gunningham SP, Currie MJ, Han C, et al: The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6:4278-4286, 2000
23. Jacquemier J, Mathoulin-Portier MP, Valtola R, et al: Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3. Int J Cancer 89:69-73, 2000
24. O-charoenrat P, Rhys-Evans P, Eccles SA: Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92:556-568, 2001
25. Niki T, Iba S, Tokunou M, et al: Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6:2431-2439, 2000
26. Ichikura T, Tomimatsu S, Ohkura E, et al: Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol 78:132-137, 2001
27. Takahashi A, Kono K, Itakura J, et al: Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer. Oncology 62:121-127, 2002
28. Amioka T, Kitadai Y, Tanaka S, et al: Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 38:1413-1419, 2002
29. Yonemura Y, Endo Y, Fujita H, et al: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5:1823-1829, 1999
30. Yonemura Y, Fushida S, Bando E, et al: Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 37:918-923, 2001
31. Liu XE, Sun XD, Wu JM: Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol 10:352-355, 2004
32. Hamilton SR, Aaltonen LA WHO Classification. Tumours of the Digestive System: Pathology & Genetics. Lyon, France, IARC Press, 2000
33. Wittekind C, Meyer HJ, Bootz F: TNM Classification of Malignant Tumors (ed 6). New York, NY, John Wiley & Sons Inc, 2002
34. Schäfer G, Cramer T, Suske G, et al: Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 278:8190-8198, 2003
35. Banerji S, Ni J, Wang SX, et al: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801, 1999
36. Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol 10:302-313, 1993
37. Huang HY, Ho CC, Huang PH, et al: Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Lab Invest 81:1729-1734, 2001
38. Katai H, Yoshimura K, Maruyama K, et al: Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer 88:1796-1800, 2000
39. Klein KE, Hermans J, van Krieken JH, et al: Evaluation of the 5th edition of the TNM classification for gastric cancer: Improved prognostic value. Br J Cancer 84:64-71, 2001
40. Jung YD, Mansfield PF, Akagi M, et al: Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model. Eur J Cancer 38:1133-1140, 2002
41. Kamiyama M, Ichikawa Y, Ishikawa T, et al: VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice. Cancer Gene Ther 9:197-201, 2002
42. Duff SE, Li C, Jeziorska M, et al: Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 89:426-430, 2003
43. Kitadai Y, Amioka T, Haruma K, et al: Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 93:662-666, 2001
44. Akagi K, Ikeda Y, Miyazaki M, et al: Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 83: 887-891, 2000
45. Mandriota SJ, Jussila L, Jeltsch M, et al: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682, 2001
46. Skobe M, Hawighorst T, Jackson DG, et al: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198, 2001
47. Karpanen T, Egeblad M, Karkkainen MJ, et al: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786-1790, 2001
48. Stacker SA, Caesar C, Baldwin ME, et al: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191, 2001
49. Karpanen T, Alitalo K: Lymphatic vessels as targets of tumor therapy? J Exp Med 194:F37-F42, 2001
50. Skobe M, Hamberg LM, Hawighorst T, et al: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 159:893-903, 2001
51. Ishikawa M, Kitayama J, Kazama S, et al: Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 33:21-27, 2003
52. Kabashima A, Maehara Y, Kakeji Y, et al: Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 60:146-150, 2001
53. George ML, Tutton MG, Janssen F, et al: VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3:420-427, 2001
54. Okamoto M, Nishimine M, Kishi M, et al: Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 31:227-233, 2002
55. Moriyama M, Kumagai S, Kawashiri S, et al: Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33:369-374, 1997
56. He Y, Kozaki K, Karpanen T, et al: Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825, 2002
57. Shimizu K, Kubo H, Yamaguchi K, et al: Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95:328-333, 2004
58. Jain RK, Fenton BT: Intratumoral lymphatic vessels: A case of mistaken identity or malfunction? J Natl Cancer Inst 94:417-421, 2002
59. Padera TP, Kadambi A, di Tomaso E, et al: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883-1886, 2002